A RAPIDLY GROWING DRUG CLASS WITH GREAT POTENTIAL

Oligonucleotides are a class of biotherapeutics presenting complex challenges in the development and commercialization of gene therapies. Download our paper and learn how to move your project forward.

LEARN HOW TO MOVE THROUGH EVOLVING CHALLENGES IN BIOTHERAPEUTICS.▸

EXPERIENCE MATTERS

In the rapidly developing field of gene therapy, Pace® is considered an experienced veteran. Since 2015 we have worked closely with our customer-partners to accelerate processes and provide support throughout the gene therapy product development cycle.

PACE Pharmaceutical & Biopharmaceutical Product Development